Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

A multi-year trajectory for the 2022-2024 health care budget in Belgium

22 Mar 2021

On March 4, 2021, INAMI-RIZIV announced the development of a multi-year trajectory for the health care budget in which will define the allocation of resources for health care objectives for 2022-2024.

This trajectory is intended not to save money but to choose the best way of using resources in order to improve the health care system. The health care goals for the period of 2022-2024 will be defined by June 30, 2021, with the subsequent publication of the report with the first version of the 2022 budget and a concrete multi-year budgetary framework.

The full details can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).